Trademark Overview
On Tuesday, February 20, 2024, a trademark application was filed for ANEMOCYTE with the United States Patent and Trademark Office. The USPTO has given the ANEMOCYTE trademark a serial number of 79404747. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, June 9, 2025. This trademark is owned by ANEMOCYTE S.R.L.. The ANEMOCYTE trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:
Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; medicines for dental purposes; chemical preparations for pharmaceutical or medical purposes, namely for oncology and immuno-oncology, respiratory, infectious diseases, flu, covid, cardiovascular, dermatology, rare diseases, metabolic diseases; biological preparations for the treatment of cancer, respiratory diseases, infectious diseases, flu, covid, cardiovascular diseases, dermatology diseases, rare diseases, metabolic diseases; biological reagents for medical purposes; vaccines; nucleic acid sequences for medical and veterinary products; dietetic foods adapted for medical use; antibodies for medical purposes; dietary supplements; pharmaceutical preparations for treating diabetes; diagnostic preparations for medical purposes; Biolofical tissue cultures fo rmedical use
Medical instruments for cutting tissue; Surgical apparatus and instruments for medical, dental or veterinary use; Medical devices for use in treating or cancer, respiratory diseases, infectious diseases, flu, covid, cardiovascular diseases, dermatology diseases, rare diseases, metabolic diseases; Electro-surgical motors being part of surgical and medical apparatus and instruments for use in general surgery
Research and development of vaccines and medicines; scientific and technological services Scientific and technological services, namely manufacturing, scientific research, innovation and development, process development, analysis, testing, storage, stability studies, regulatory support in the field of cell and gene therapies, DNA and RNA; Research and development services in the field of medical preparations; medical research laboratories; design and development of computer hardware and computer software; scientific research; research and development services of new pharmaceutical products.